{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:40:46Z","timestamp":1794559246217,"version":"4.9.1"},"reference-count":25,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4,26]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Ibrutinib may be associated with invasive fungal infections especially IA. Most infections usually occur during the first months of treatment, often in patients with other risk factors for fungal infections.<\/jats:p>","DOI":"10.1182\/blood-2017-11-818286","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T13:10:47Z","timestamp":1517490647000},"page":"1955-1959","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":294,"title":["Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib"],"prefix":"10.1182","volume":"131","author":[{"given":"David","family":"Ghez","sequence":"first","affiliation":[{"name":"D\u00e9partement d\u2019H\u00e9matologie, Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Calleja","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, Groupe hospitalier l'Archet, Nice, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Protin","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Baron","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, H\u00f4pital de la Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Ledoux","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie et d'Oncologie, H\u00f4pital de Hautepierre, Centre Hospitalier Universitaire Strasbourg, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, Centre Hospitalier R\u00e9gional Universitaire, Caen, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Dupont","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses, Centre Hospitalier de Saint Malo, Saint Malo, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dreyfus","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, Centre Hospitalier Universitaire, Poitiers, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Ferrant","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, Centre Hospitalier Lyon Sud, Pierre-B\u00e9nite, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Herbaux","sequence":"additional","affiliation":[{"name":"Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, H\u00f4pital Huriez, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Laribi","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, Centre Hospitalier du Mans, Le Mans, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Le Calloch","sequence":"additional","affiliation":[{"name":"M\u00e9decine Interne-Maladies du sang-Maladies Infectieuses, Centre Hospitalier de Cornouaille, Quimper, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Malphettes","sequence":"additional","affiliation":[{"name":"Service d\u2019Immuno-H\u00e9matologie, H\u00f4pital Saint Louis, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciane","family":"Paul","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, H\u00f4pital Saint Eloi, CHU Montpellier, Montpellier, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Souchet","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, H\u00f4pital de la Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Truchan-Graczyk","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine, Centre Hospitalier de Saumur, Saumur, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Delavigne","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dartigeas","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie et Th\u00e9rapie cellulaire, H\u00f4pital Bretonneau, Centre Hospitalier Universitaire Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Ysebaert","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111906002747700_B1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(15)00465-9","article-title":"Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study","volume":"17","author":"Chanan-Khan","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"2019111906002747700_B2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"issue":"25","key":"2019111906002747700_B3","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"2019111906002747700_B4","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2016-06-722991","article-title":"Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib","volume":"128","author":"Ahn","year":"2016","journal-title":"Blood"},{"key":"2019111906002747700_B5","first-page":"27","article-title":"Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia","volume":"21","author":"Arthurs","year":"2017","journal-title":"Respir Med Case Rep"},{"issue":"12","key":"2019111906002747700_B6","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1080\/10428194.2017.1320710","article-title":"Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis","volume":"58","author":"Baron","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"2019111906002747700_B7","first-page":"1593","article-title":"Ibrutinib for chronic lymphocytic leukemia","volume":"374","author":"Ruchlemer","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111906002747700_B8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2159-8290.CD-17-0613","article-title":"Ibrutinib unmasks critical role of Bruton tyrosine kinase in primary CNS lymphoma","volume":"7","author":"Grommes","year":"2017","journal-title":"Cancer Discov"},{"issue":"6","key":"2019111906002747700_B9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ccell.2017.04.012","article-title":"Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma","volume":"31","author":"Lionakis","year":"2017","journal-title":"Cancer Cell"},{"issue":"8","key":"2019111906002747700_B10","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"issue":"12","key":"2019111906002747700_B11","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"2019111906002747700_B12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J Infect"},{"issue":"3","key":"2019111906002747700_B13","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.3324\/haematol.2016.151837","article-title":"Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study","volume":"102","author":"Tisi","year":"2017","journal-title":"Haematologica"},{"issue":"suppl 1","key":"2019111906002747700_B14","first-page":"Abstract 4327","article-title":"Invasive aspergillosis in chronic lymphocytic leukemia: therapy and outcomes [abstract]","volume":"130","author":"Duma","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2019111906002747700_B15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ccell.2017.05.004","article-title":"Ibrutinib in PCNSL: the curious cases of clinical responses and aspergillosis","volume":"31","author":"Grommes","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111906002747700_B16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"issue":"1","key":"2019111906002747700_B17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cid\/cix687","article-title":"Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways","volume":"66","author":"Chamilos","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"2019111906002747700_B18","first-page":"Abstract 4323","article-title":"Ibrutinib: a risk factor for invasive fungal infections? [abstract]","volume":"130","author":"Ruchlemer","year":"2017","journal-title":"Blood"},{"issue":"19","key":"2019111906002747700_B19","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2015-04-639203","article-title":"Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib","volume":"126","author":"Sun","year":"2015","journal-title":"Blood"},{"issue":"suppl 1","key":"2019111906002747700_B20","first-page":"Abstract 3460","article-title":"Systematic review of infectious events in prospective trials of ibrutinib [abstract]","volume":"130","author":"Tillman","year":"2017","journal-title":"Blood."},{"issue":"suppl 1","key":"2019111906002747700_B21","first-page":"Abstract 803","article-title":"Incidence and type of opportunistic infections during ibrutinib treatment at a single academic center [abstract]","volume":"130","author":"Rogers","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2019111906002747700_B22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2010-04-281170","article-title":"Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia","volume":"117","author":"Fiedler","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111906002747700_B23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.15252\/emmm.201404556","article-title":"Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus","volume":"7","author":"Herbst","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"6","key":"2019111906002747700_B24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005792-199611000-00001","article-title":"X-linked agammaglobulinemia. A clinical and molecular analysis","volume":"75","author":"Ochs","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"2019111906002747700_B25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/591458","article-title":"Human platelets attenuate Aspergillus species via granule-dependent mechanisms","volume":"198","author":"Perkhofer","year":"2008","journal-title":"J Infect Dis"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/17\/1955\/1405910\/blood818286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/17\/1955\/1405910\/blood818286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T06:00:50Z","timestamp":1574143250000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/131\/17\/1955\/36746\/Earlyonset-invasive-aspergillosis-and-other-fungal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":25,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,4,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-11-818286","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732656056.793562616","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]}}}